Intravesical silver nitrate for refractory hemorrhagic cystitis

Brian D. Montgomery, Stephen A. Boorjian, Matthew J. Ziegelmann, Daniel D. Joyce, Brian J. Linder

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Hemorrhagic cystitis is a challenging clinical entity with limited evidence available to guide treatment. The use of intravesical silver nitrate has been reported, though supporting literature is sparse. Here, we sought to assess outcomes of patients treated with intravesical silver nitrate for refractory hemorrhagic cystitis. Material and methods: We identified nine patients with refractory hemorrhagic cystitis treated at our institution with intravesical silver nitrate between 2000-2015. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after silver nitrate instillation prior to hospital discharge. Results: Median patient age was 80 years (IQR 73, 82). Radiation was the most common etiology for hemorrhagic cystitis 89% (8/9). Two patients underwent high dose (0.1%-0.4%) silver nitrate under anesthesia, while the remaining seven were treated with doses from 0.01% to 0.1% via continuous bladder irrigation for a median of 3 days (range 2-4). All nine patients (100%) had persistent hematuria despite intravesical silver nitrate therapy, requiring additional interventions and red blood cell transfusion during the hospitalization. There were no identified complications related to intravesical silver nitrate instillation. Conclusion: Although well tolerated, we found that intravesical silver nitrate was ineffective for bleeding control, suggesting a limited role for this agent in the management of patients with hemorrhagic cystitis.

Original languageEnglish (US)
Pages (from-to)197-201
Number of pages5
JournalTurk Uroloji Dergisi
Volume42
Issue number3
DOIs
StatePublished - Sep 1 2016

Fingerprint

Silver Nitrate
Cystitis
Urinary Bladder
Erythrocyte Transfusion
Hematuria
Therapeutics
Hospitalization
Anesthesia
Radiation
Hemorrhage

Keywords

  • Bladder
  • Hematuria
  • Hemorrhagic cystitis
  • Intravesical
  • Silver nitrate

ASJC Scopus subject areas

  • Urology

Cite this

Montgomery, B. D., Boorjian, S. A., Ziegelmann, M. J., Joyce, D. D., & Linder, B. J. (2016). Intravesical silver nitrate for refractory hemorrhagic cystitis. Turk Uroloji Dergisi, 42(3), 197-201. https://doi.org/10.5152/tud.2016.38445

Intravesical silver nitrate for refractory hemorrhagic cystitis. / Montgomery, Brian D.; Boorjian, Stephen A.; Ziegelmann, Matthew J.; Joyce, Daniel D.; Linder, Brian J.

In: Turk Uroloji Dergisi, Vol. 42, No. 3, 01.09.2016, p. 197-201.

Research output: Contribution to journalArticle

Montgomery, BD, Boorjian, SA, Ziegelmann, MJ, Joyce, DD & Linder, BJ 2016, 'Intravesical silver nitrate for refractory hemorrhagic cystitis', Turk Uroloji Dergisi, vol. 42, no. 3, pp. 197-201. https://doi.org/10.5152/tud.2016.38445
Montgomery BD, Boorjian SA, Ziegelmann MJ, Joyce DD, Linder BJ. Intravesical silver nitrate for refractory hemorrhagic cystitis. Turk Uroloji Dergisi. 2016 Sep 1;42(3):197-201. https://doi.org/10.5152/tud.2016.38445
Montgomery, Brian D. ; Boorjian, Stephen A. ; Ziegelmann, Matthew J. ; Joyce, Daniel D. ; Linder, Brian J. / Intravesical silver nitrate for refractory hemorrhagic cystitis. In: Turk Uroloji Dergisi. 2016 ; Vol. 42, No. 3. pp. 197-201.
@article{d4c75c0aadc044dca2adaeabfe349b26,
title = "Intravesical silver nitrate for refractory hemorrhagic cystitis",
abstract = "Objective: Hemorrhagic cystitis is a challenging clinical entity with limited evidence available to guide treatment. The use of intravesical silver nitrate has been reported, though supporting literature is sparse. Here, we sought to assess outcomes of patients treated with intravesical silver nitrate for refractory hemorrhagic cystitis. Material and methods: We identified nine patients with refractory hemorrhagic cystitis treated at our institution with intravesical silver nitrate between 2000-2015. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after silver nitrate instillation prior to hospital discharge. Results: Median patient age was 80 years (IQR 73, 82). Radiation was the most common etiology for hemorrhagic cystitis 89{\%} (8/9). Two patients underwent high dose (0.1{\%}-0.4{\%}) silver nitrate under anesthesia, while the remaining seven were treated with doses from 0.01{\%} to 0.1{\%} via continuous bladder irrigation for a median of 3 days (range 2-4). All nine patients (100{\%}) had persistent hematuria despite intravesical silver nitrate therapy, requiring additional interventions and red blood cell transfusion during the hospitalization. There were no identified complications related to intravesical silver nitrate instillation. Conclusion: Although well tolerated, we found that intravesical silver nitrate was ineffective for bleeding control, suggesting a limited role for this agent in the management of patients with hemorrhagic cystitis.",
keywords = "Bladder, Hematuria, Hemorrhagic cystitis, Intravesical, Silver nitrate",
author = "Montgomery, {Brian D.} and Boorjian, {Stephen A.} and Ziegelmann, {Matthew J.} and Joyce, {Daniel D.} and Linder, {Brian J.}",
year = "2016",
month = "9",
day = "1",
doi = "10.5152/tud.2016.38445",
language = "English (US)",
volume = "42",
pages = "197--201",
journal = "Turk Uroloji Dergisi",
issn = "1300-5804",
publisher = "Aves",
number = "3",

}

TY - JOUR

T1 - Intravesical silver nitrate for refractory hemorrhagic cystitis

AU - Montgomery, Brian D.

AU - Boorjian, Stephen A.

AU - Ziegelmann, Matthew J.

AU - Joyce, Daniel D.

AU - Linder, Brian J.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objective: Hemorrhagic cystitis is a challenging clinical entity with limited evidence available to guide treatment. The use of intravesical silver nitrate has been reported, though supporting literature is sparse. Here, we sought to assess outcomes of patients treated with intravesical silver nitrate for refractory hemorrhagic cystitis. Material and methods: We identified nine patients with refractory hemorrhagic cystitis treated at our institution with intravesical silver nitrate between 2000-2015. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after silver nitrate instillation prior to hospital discharge. Results: Median patient age was 80 years (IQR 73, 82). Radiation was the most common etiology for hemorrhagic cystitis 89% (8/9). Two patients underwent high dose (0.1%-0.4%) silver nitrate under anesthesia, while the remaining seven were treated with doses from 0.01% to 0.1% via continuous bladder irrigation for a median of 3 days (range 2-4). All nine patients (100%) had persistent hematuria despite intravesical silver nitrate therapy, requiring additional interventions and red blood cell transfusion during the hospitalization. There were no identified complications related to intravesical silver nitrate instillation. Conclusion: Although well tolerated, we found that intravesical silver nitrate was ineffective for bleeding control, suggesting a limited role for this agent in the management of patients with hemorrhagic cystitis.

AB - Objective: Hemorrhagic cystitis is a challenging clinical entity with limited evidence available to guide treatment. The use of intravesical silver nitrate has been reported, though supporting literature is sparse. Here, we sought to assess outcomes of patients treated with intravesical silver nitrate for refractory hemorrhagic cystitis. Material and methods: We identified nine patients with refractory hemorrhagic cystitis treated at our institution with intravesical silver nitrate between 2000-2015. All patients had failed previous continuous bladder irrigation with normal saline and clot evacuation. Treatment success was defined as requiring no additional therapy beyond normal saline irrigation after silver nitrate instillation prior to hospital discharge. Results: Median patient age was 80 years (IQR 73, 82). Radiation was the most common etiology for hemorrhagic cystitis 89% (8/9). Two patients underwent high dose (0.1%-0.4%) silver nitrate under anesthesia, while the remaining seven were treated with doses from 0.01% to 0.1% via continuous bladder irrigation for a median of 3 days (range 2-4). All nine patients (100%) had persistent hematuria despite intravesical silver nitrate therapy, requiring additional interventions and red blood cell transfusion during the hospitalization. There were no identified complications related to intravesical silver nitrate instillation. Conclusion: Although well tolerated, we found that intravesical silver nitrate was ineffective for bleeding control, suggesting a limited role for this agent in the management of patients with hemorrhagic cystitis.

KW - Bladder

KW - Hematuria

KW - Hemorrhagic cystitis

KW - Intravesical

KW - Silver nitrate

UR - http://www.scopus.com/inward/record.url?scp=84984788823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984788823&partnerID=8YFLogxK

U2 - 10.5152/tud.2016.38445

DO - 10.5152/tud.2016.38445

M3 - Article

VL - 42

SP - 197

EP - 201

JO - Turk Uroloji Dergisi

JF - Turk Uroloji Dergisi

SN - 1300-5804

IS - 3

ER -